|
| |
|
|
NOVABIOTICS AIMING HIGH FOR 2006!
|
NovaBiotics have had a very successful and certainly full year. The company moved to larger premises north of Aberdeen city centre in order to accommodate recent growth within the company.
They were delighted to have won Scottish Enterprise's Most Promising New Life Science Company 2005 award at the Thistle/Scottish Life Science dinner 2006 and are equally pleased to have been short-listed as finalists in the Sir Ian Wood Innovation category of the Grampian Business Awards 2006.
The business is completing a significant pre- IPO funding round in order to take its lead product (a topical antifungal for the treatment of nail fungus) into the clinic later this year and to further develop its exciting anti-infectives pipeline and as reported in recent press, intends to float on AIM in 2007. For more information click through to www.novabiotics.co.uk
|
|
|
A touch of French flair helps bridge skills gap
|
As we are all aware, there are some serious skills shortages in certain industries across Scotland. The biotechnology sector is of course no stranger to this situation. However, NovaBiotics Ltd, a company based in Aberdeen, is utilising a unique and effective way to tackle the problem: sourcing and recruiting talented international postgraduates through Scottish Networks International (SNI), a trade development initiative managed by British Council Scotland in partnership with Scottish Development International.
|
|
|
COMPANIES UK SCOTLAND FOCUS: Life sciences set to offer economy boost
|
Life sciences offer great opportunities to the Scottish economy, according to John Pool, who, for the past six years, has been business adviser on biotechnology to Scottish Enterprise, the development body.
However, Mr Pool could never be accused of just advising from the sidelines. He is chairman of Idmos, the Dundee-based company that specialises in detecting dental decay and which floated on Aim with a market value of £20m slightly more than a year ago.
|
|
|
BROAD RANGE OF ENTERPRISING ACHIEVERS HONOURED AT AWARDS
|
A Long-established dairy based at Inverurie and the youngest life-science company in Aberdeen were among the winners in this year's Grampian Awards for Business Enterprise.
Around 400 people attended the awards ceremony last night at the Ardoe House Hotel, near Aberdeen, where the keynote speaker was Dragons' Den judge Rachel Elnaugh.
The awards, which recognise business achievement by companies of all sizes and enterprising individuals, are organised by Enterprise North East Trust and sponsored by the Royal Bank of Scotland (RBS) and Business Gateway in association with Scottish Enterprise Grampian.
|
|
|
SHORTLIST FOR ENTERPRISE AWARDS POSTED
|
| The list of first-round finalists for the 2006 Grampian Awards for Business Enterprise has been announced. There was a record number of entries this year - 148. The awards, now in their seventh year, are organised by Enterprise North East Trust and sponsored by the Royal Bank of Scotland and Business Gateway supported by Scottish Enterprise Grampian.
|
|
|
COMPANIES UK SCOTLAND FOCUS: Life sciences set to offer economy boost
|
| Life sciences offer great opportunities to the Scottish economy, according to John Pool, who, for the past six years, has been business adviser on biotechnology to Scottish Enterprise, the development body.
However, Mr Pool could never be accused of just advising from the sidelines. He is chairman of Idmos, the Dundee-based company that specialises in detecting dental decay and which floated on Aim with a market value of £20m slightly more than a year ago.
|
|
|
SCOTS COMPANIES IN LINE FOR SCIENCE 'OSCARS'
|
| Three north of Scotland companies are in the running to receive prestigious life sciences "Oscars". In Dundee, Professor Sir Philip Cohen, of Dundee University, and IDMos, a pioneering disease detection company, have been shortlisted for a Scottish Life Sciences award. Aberdeen company NovaBiotics Ltd, which focuses on diseases which cannot be treated, including MRSA, has also been nominated. The awards recognise groundbreaking developments in healthcare, nutrition, medical devices and disease prevention within Scotland's life sciences community. They are backed by Scottish Enterprise.
|
|
|
SHORTLIST FOR ENTERPRISE AWARDS POSTED
|
The list of first-round finalists for the 2006 Grampian Awards for Business Enterprise has been announced.
There was a record number of entries this year - 148.
The awards, now in their seventh year, are organised by Enterprise North East Trust and sponsored by the Royal Bank of Scotland and Business Gateway supported by Scottish Enterprise Grampian.
|
|
|
NovaBiotics and Aircraft Medical set to join AIM
|
TWO fledgling Scottish biotech firms are hoping to become the next high growth companies in the sector, unveiling plans to float on the junior stock-market in 2006.
NovaBiotics, an Aberdeen-based firm developing two anti-infection drugs, told The Scotsman it was in the "last phase" of the process towards a flotation on the Alternative Investment Market, and was targeting the second or third quarter for its public debut.
|
|
|
SCOTS COMPANIES IN LINE FOR SCIENCE 'OSCARS'
|
Three north of Scotland companies are in the running to receive prestigious life sciences "Oscars".
In Dundee, Professor Sir Philip Cohen, of Dundee University, and IDMos, a pioneering disease detection company, have been shortlisted for a Scottish Life Sciences award.
Aberdeen company NovaBiotics Ltd, which focuses on diseases which cannot be treated, including MRSA, has also been nominated.
The awards recognise groundbreaking developments in healthcare, nutrition, medical devices and disease prevention within Scotland's life sciences community. They are backed by Scottish Enterprise.
|
|
|
EVENT TO GIVE A SHOT IN THE ARM TO ABERDEEN DRUG DEVELOPMENT FIRMS
|
Scientists from some of the UK's top drug research and development companies are gathering at Aberdeen
University tomorrow for an influential life sciences conference. KEITH FINDLAY takes a look at why Aberdeen
is fertile territory for a growing list of firms in a sector with enormous potential
Aberdeen's reputation for research in the life sciences has led to the city being chosen to host the BioIndustry
Association's (BIA) first conference.
It takes place at Aberdeen University's institute of medical sciences tomorrow, when about 80 scientists from
throughout the UK will get together to discuss the latest developments.
|
|
|
Expertise injected into NovaBiotics' Management Team
|
NovaBiotics announces the appointment of Dr. Derry Mercer & Dr. Christopher Bamford as Research and Development Executives. Chris and Derry will manage the company's immunology and microbiology preclinical research programmes respectively, assisted by Dr. Colin Stewart (head of microbiology) and our team of research assistants. Derry & Chris will also co-ordinate the development of our first application with our formulation collaborators and strategic partners.
|
|
|
Antimicrobial peptides the focus of new Scottish firm
|
| Taken for Granted. Nail fungus in humans is not a pretty sight – just check out the pictures on the NovaBiotics website. According to the company’s lively managing director, scientist Deborah O’Neil, there is a gap in the market for effective anti-microbials to clear up this sort of horror. Read more.
|
|
|
Dr. David Galloway Appointed as Clinical Director
|
NovaBiotics' are pleased to announce the appointment of Dr. David Galloway as Clinical Director. David brings a wealth of experience and a globally recognized reputation in regulatory affairs and clinical trial design and management to the team. David's local links with clinicians will be key in facilitating NovaBiotics first clinical trials in 2006. We look forward to benefiting from David's input into the company.
|
|
|
Teleinformatics Newsletter
|
NovaBiotics success begins with support from TeleInformatics. Laboratory research data managed on specialist IT system. Aberdeen drug research pioneer, NovaBiotics Ltd is an innovative biotechnology company focusing on the design and application of novel antimicrobials to treat diseases for which there are no effective, safe or resistance-free therapies. Read more.
|
|
|
BIA Life sciences - newsletter
|
Dr Deborah O'Neil of NovaBiotics writes "Italy's biannual showcase of Biotechnology was held in April in the historic University city of Padua. The conference provided an overview of what Italy's biotechnology sector has to offer and the opportunity to make contact and forge links with the key players and companies therein.
|
|
|
Insider Magazine Article
|
Taken for Granted. Nail fungus in humans is not a pretty sight - just check out the pictures on the NovaBiotics website.
According to the company's lively managing director, scientist Deborah O'Neil, there is a gap in the market for effective anti-microbials to clear up this sort of horror. Read more.
|
|
|
|
|
|
|
|
|
